文献速递临床试验与 GCP流行病学与生物统计

INITIATE试验方案:急诊科戒烟卡干预对长期戒烟的随机对照试验

The INITIATE trial protocol: a randomized controlled trial testing the effectiveness of a "quit card" intervention on long-term abstinence among tobacco smokers presenting to the emergency department.
PubMed 文献 · Trials · 2021-10-23

本研究为多中心、前瞻性、单盲、盲法评估终点的随机对照试验,在四个急诊科招募吸烟患者,比较戒烟卡干预与常规护理的效果。干预组接受价值300加元的戒烟卡、自助手册及6个月电话随访咨询,常规组仅接受当地戒烟项目手册。主要结局为26周时生化验证的戒烟率,假设干预组戒烟率更高、健康结局改善且医疗利用减少。

要点

  • 急诊科是启动戒烟干预的未充分利用场景。
  • 戒烟卡干预包含300加元NRT购买卡、手册和6个月电话咨询。
  • 主要结局为26周生化验证戒烟,随访至104周。

核心结论

  • 假设戒烟卡干预组较常规护理组有更高的26周生化验证戒烟率、更好的健康结局和更低的医疗利用。

研究设计与样本

  • 前瞻性四中心、单盲、盲法终点(PROBE)随机对照试验,在急诊科按到达时间顺序招募参与者。
  • 随机化按中心和加拿大分诊 acuity 量表(CTAS)分层,每个CTAS级别准备等量戒烟包。

关键数值与推荐

  • 干预组戒烟包包括:价值300加元、可在任意加拿大药房购买任何形式尼古丁替代疗法(NRT)的「戒烟卡」;自助手册;主动纳入6个月电话随访咨询。
  • 常规护理组戒烟包包括当地戒烟项目手册。
  • 主要结局为26周时生化验证的戒烟;次要结局包括第4、52、104周吸烟行为及死亡率和医疗利用。

临床怎么用

  • 在急诊科推行简单、可扩展的多组分戒烟干预,以弥补当前急诊戒烟治疗的不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Smoking cessation interventions implemented in emergency department (ED) settings have resulted in limited success, owing to factors such as lack of time, motivation, and incentives. A dynamic yet simple and effective approach that addresses the fast-paced nature of acute-care ED settings is needed. This study proposes a multi-center randomized controlled trial (RCT) to compare the effectiveness of an easy to deliver proactive, multi-component tobacco treatment intervention to usual care in the ED setting. METHODS: This will be a prospective four-site, single-blind, blinded-endpoint (PROBE) RCT. Participants will be recruited directly in the ED and will be approached strictly in order of arrival time. Those randomized to the Quit Card Intervention (QCI) group will receive a "quit kit" which will include: a "Quit Card" worth $300 that can be used at any Canadian pharmacy to purchase any form of nicotine replacement therapy (NRT); a self-help booklet; and proactive enrolment in 6 months of telephone follow-up counseling. The usual care (UC) group will receive a "quit kit" which will include a brochure for a local smoking cessation program. Quit kits for both groups will be delivered in opaque, sealed envelopes, and identical in size and weight so to conceal group allocation from the blinded research coordinator. Randomization will be stratified by site and by the Canadian Triage Acuity Scale (CTAS), a value assigned to each ED patient based on the severity of the condition. An equal number of quit kits will be prepared for each CTAS level. The primary outcome will be bio-chemically verified smoking abstinence at 26 weeks. Secondary outcomes include smoking behavior at weeks 4, 52, and 104 as well as mortality and health care utilization outcomes. Investigators, outcome assessors, and data analysts will be blinded to group allocation until after primary analyses are completed. It is hypothesized that the QCI group will have higher a abstinence rate, improved health outcomes, and decreased healthcare utilization. DISCUSSION: There are few examples of hospital EDs in Canada that systematically initiate tobacco cessation interventions for patients who smoke. Given the high smoking prevalence among ED patients and the relation of tobacco smoking to the majority of ambulatory care sensitive conditions, EDs are a missed opportunity in the initiation of tobacco treatment interventions. We have designed and will test an evidence-based tobacco treatment intervention that is simple and highly scalable. TRIAL REGISTRATION: ClinicalTrials.gov NCT04163081 . Registered on November 14, 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Mullen KA, Garg A, Gagnon F, et al. The INITIATE trial protocol: a randomized controlled trial testing the effectiveness of a "quit card" intervention on long-term abstinence among tobacco smokers presenting to the emergency department. Trials. 2021. PMID: 34688291. doi:10.1186/s13063-021-05693-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。